Epidemiology and Risk Factors for Clostridium difficile Infection in Children
Thomas J. Sandora(Boston Children's Hospital), Grace M. Lee, Patricia Scanlon(Boston Children's Hospital), Kathleen R. Flaherty(Memorial Sloan Kettering Cancer Center), Courtney A. Gidengil(RAND Corporation), Monica Fung(University of California, San Francisco), Gail Potter-Bynoe(Miriam Hospital), Laura Helsing(Boston Children's Hospital)
Cited by 168
Related Papers
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
|Clinical Infectious Diseases|2017|2.7k
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
|Clinical Infectious Diseases|2018|1.2k
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
COVID-19 in Immunocompromised Hosts: What We Know So Far
|Clinical Infectious Diseases|2020|568
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
|Journal of Clinical Microbiology|1994|508